LyondellBasell (LYB) and Genox Recycling have launched a collaborative plastics recycling initiative known as Genox LyondellBasell New Material Co., Ltd. (GXLYB), which has recently obtained No Objection Letters from the U.S. Food and Drug Administration (FDA).

Source: InterplasInsights

These NOLs pertain to the company’s processes for recycling polypropylene (rPP) and high-density polyethylene (rHDPE).

These two No Objection Letters are a strong endorsement of our recycling technology and products. “The joint venture is part of our strategy to expand our circular polymer offerings in China. We will continue to provide local recycling solutions that help our customers and brand owners achieve their sustainability goals.

^{Fu Limin, Vice President of Polyolefins China and Joint Venture Management at LYB, and Chairman of the Board of GXLYB}

The approval of these NOLs confirms that both processes adhere to the safety and quality standards set forth by the FDA. This achievement highlights the strength of the company’s quality control systems, encompassing everything from sourcing raw materials to production and final product testing.